Testing effectiveness (Phase 2)Study completedNCT01990859What this trial is testingPhase 2 Study of Ipilimumab in Japanese Advanced Melanoma PatientsWho this might be right forMelanoma Bristol-Myers Squibb 20
Very early researchEnded earlyNCT00499733What this trial is testingCyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT02073123What this trial is testingStudy of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic MelanomaWho this might be right forMetastatic MelanomaStage III MelanomaStage IV Melanoma NewLink Genetics Corporation 131
Large-scale testing (Phase 3)Study completedNCT03329846What this trial is testingAn Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced MelanomaWho this might be right forMelanomaSkin Cancer Bristol-Myers Squibb 20
Not applicableStudy completedNCT03504696What this trial is testingEffectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced MelanomaWho this might be right forMelanoma Bristol-Myers Squibb 400
Testing effectiveness (Phase 2)Looking for participantsNCT06797297What this trial is testingEvaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic TherapyWho this might be right forMelanoma Innovent Biologics (Suzhou) Co. Ltd. 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT05620134What this trial is testingStudy of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerWho this might be right forCancerTumor, SolidAdvanced Solid Tumor+19 more Salubris Biotherapeutics Inc 263
Large-scale testing (Phase 3)Looking for participantsNCT06246916What this trial is testingA Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)Who this might be right forMelanoma Regeneron Pharmaceuticals 560
Testing effectiveness (Phase 2)Looking for participantsNCT06265025What this trial is testingGM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid TumorsWho this might be right forHead and Neck CancerMalignant MelanomaColorectal Cancer+3 more GeneMedicine Co., Ltd. 125
Not applicableLooking for participantsNCT04045691What this trial is testingBinimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma TreatmentWho this might be right forMelanoma Stage IVMelanoma Stage III Pierre Fabre Pharma GmbH 750
Testing effectiveness (Phase 2)UnknownNCT04472806What this trial is testingMaintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal MelanomaWho this might be right forMucosal Melanoma Fudan University 31
Not applicableWithdrawnNCT03205722What this trial is testingThe Effectiveness of Nivolumab Monotherapy as First-Line Therapy in Adults With Advanced Melanoma in GermanyWho this might be right forMelanoma Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00700882What this trial is testingDasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By SurgeryWho this might be right forMelanoma (Skin) Eastern Cooperative Oncology Group 81
Testing effectiveness (Phase 2)Looking for participantsNCT05269381What this trial is testingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more Mayo Clinic 138
Testing effectiveness (Phase 2)Ended earlyNCT01586195What this trial is testingStudy Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600EWho this might be right forMalignant Melanoma Genentech, Inc. 31
Not applicableStudy completedNCT02990611What this trial is testingObservational Study of Nivolumab Monotherapy or in Combination With Ipilimumab in Participants With Advanced Melanoma and in Participants With Adjuvant Nivolumab TherapyWho this might be right forMelanoma Bristol-Myers Squibb 1,087
Early research (Phase 1)Study completedNCT01005472What this trial is testingTemozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant MelanomaWho this might be right forMetastatic Melanoma Jonsson Comprehensive Cancer Center 16
Testing effectiveness (Phase 2)Looking for participantsNCT05267626What this trial is testingStudy of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic CancerWho this might be right forAdvanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more Aulos Bioscience, Inc. 159
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07619898What this trial is testingPHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid ExposureWho this might be right forColitisHepatitisMelanoma (Skin Cancer) Therakos LLC 112
Large-scale testing (Phase 3)Study completedNCT01844505What this trial is testingPhase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)Who this might be right forUnresectable or Metastatic Melanoma Bristol-Myers Squibb 945